CANTON, Mass., April 3 /PRNewswire/ -- Digilab, Inc. is pleased to announce an exclusive Distributorship Agreement with Boehringer Ingelheim microParts GmbH for the Americas and Australia. In these markets Digilab will be sole distributor of microParts’ UV-Vis microspectrometer for both OEM and end-user applications.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/CLTH011LOGO )
Digilab will also be prepared to assume the OEM customer interface responsibility for existing Boehringer Ingelheim microParts accounts in the Americas and Australia. In addition to developing new OEM applications and customers, Digilab will be using its channels to sell UV/Vis end user applications packages where affordable field use or laboratory bench solutions are not now available.
With over 50 years of applications, systems, and solutions expertise in spectroscopy Digilab is well positioned to create both the OEM partnerships and end user relationships needed to assure widespread adoption and use of microParts’ optical micro-system-technology components and products. Target markets and applications for the Digilab microParts’ microspectrometer are broad covering such high growth areas as life sciences and healthcare, industrial process control, and security. microParts’ microspectrometers are OEM components today of applications in each of these major global markets.
Dr. Joachim Eicher, Senior Vice President of Boehringer Ingelheim microParts commented “although conventional spectroscopic instruments and devices can analyze just about any material or biological substance to determine its unique “molecular signature,” these devices will truly become ubiquitous when they are miniaturized sufficiently to be put into the hands of end users for point of use applications. We are confident Digilab’s commitment to technology and product platforms in sample preparation, bioinformatics (biomarkers), and spectroscopy makes them uniquely well suited to fully develop the at-line, in-line, and handheld market potential of microParts’ microspectrometer product line in the Americas and Australia. Boehringer Ingelheim microParts applications tailored spectral sensors offer the immediate results with the optimal specificity required to make these types of applications possible.”
David T. Giddings, Digilab’s President & CEO commented “the Boehringer Ingelheim microParts relationship is an important step forward in our company’s strategy to “Identify What Matters” for the life sciences research, near patient care, and point of need molecular detection and analysis markets. Digilab’s relationship with microParts goes beyond this exciting distribution partnership as we want to make use of their extensive microsystems and microfluidics technologies, development, and manufacturing expertise to support Digilab’s advanced molecular spectroscopy product and applications development programs.”
About Digilab
As a global leader in molecular spectroscopy systems, Digilab develops innovative and differentiated products and services for the life sciences research and clinical diagnostics markets. The company’s pioneering work for the U.S. Government in 1969 led to the development, manufacture, sales and service of the first commercial Fourier-Transform InfraRed (FTIR) spectrometer. In the fall of 2004, Digilab sold its FTIR molecular spectroscopy assets to Varian Inc. Since then, the company has remained focused on novel and proprietary sample preparation, bioinformatics, and spectroscopy detection/analysis devices which can be integrated into solutions for research and diagnostics applications.
Digilab has had agreements with such companies as AstraZeneca, Boehringer Ingelheim, Merck & Co, Novartis, Novo Nordisk, Roche Diagnostics, Abbott, Johnson and Johnson, and Solvay Pharmaceuticals for its Peptidomics(R) sample preparation and biomarker discovery, validation, and development products and services.
For more information about Digilab contact: Cindy Gong, Product Manager at cgong@digilabglobal.com or (765) 497-5853
About Boehringer Ingelheim microParts GmbH
Boehringer Ingelheim microParts GmbH develops, manufactures and sells micro-system-technology (MST) products for applications in diagnostics and analytics. The company is one of the leading international companies in the MST sector and one of the leading suppliers of microstructured components and systems in the biomedical field. The product range includes technically advanced and innovative mechanical, optical and fluidic products manufactured from a wide variety of plastics, metals and silicon.
The company’s activities focus on the precise reproduction of very small structures in the microscopic range through the use of highly-developed injection molding methods. With its unique technological platform, Boehringer Ingelheim microParts develops products and implements new ideas as a competent partner for international customers. Services include design development, prototype manufacturing, mass production and worldwide marketing. Examples of products are propellant free inhaler systems (Respimat(R) Soft Mist Inhaler), microstructured reaction platforms (lab on a chip-systems) and microspectrometers.
Photo: http://www.newscom.com/cgi-bin/prnh/20061221/CLTH011LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comDigilab, Inc.
CONTACT: Cindy Gong, Product Manager of Digilab Inc., +1-765-497-5853,cgong@digilabglobal.com; Dr. Stefan Kreuzberger, Public Relations Managerof Boehringer Ingelheim microParts GmbH, +49 231 9799-113,Stefan.Kreuzberger@microparts.de
Web site: http://www.digilabglobal.com/
